175 related articles for article (PubMed ID: 10367843)
1. Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients.
Hurle R; Losa A; Manzetti A; Lembo A
Urology; 1999 Jun; 53(6):1144-8. PubMed ID: 10367843
[TBL] [Abstract][Full Text] [Related]
2. Upper tract transitional cell carcinoma following cystectomy for bladder cancer.
Huguet-Pérez J; Palou J; Millán-Rodríguez F; Salvador-Bayarri J; Villavicencio-Mavrich H; Vicente-Rodríguez J
Eur Urol; 2001 Sep; 40(3):318-23. PubMed ID: 11684849
[TBL] [Abstract][Full Text] [Related]
3. Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG.
Miller EB; Eure GR; Schellhammer PF
Urology; 1993 Jul; 42(1):26-30. PubMed ID: 8328123
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.
Palou J; Rodríguez-Rubio F; Huguet J; Segarra J; Ribal MJ; Alcaraz A; Villavicencio H
J Urol; 2005 Sep; 174(3):859-61; discussion 861. PubMed ID: 16093970
[TBL] [Abstract][Full Text] [Related]
5. Upper tract tumors in patients with primary bladder cancer followed for 15 years.
Herr HW; Cookson MS; Soloway SM
J Urol; 1996 Oct; 156(4):1286-7. PubMed ID: 8808855
[TBL] [Abstract][Full Text] [Related]
6. [Metachronous tumors of the upper urinary tract following primary superficial tumors of the bladder].
Ojea Calvo A; Rodríguez Alonso A; Pérez García D; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Nogueira March JL
Actas Urol Esp; 2000 Jan; 24(1):31-4. PubMed ID: 10746372
[TBL] [Abstract][Full Text] [Related]
7. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
8. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
Wright JL; Hotaling J; Porter MP
J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
[TBL] [Abstract][Full Text] [Related]
9. Upper tract urothelial tumor after transurethral resection for bladder tumor.
Palou J; Fariña LA; Villavicencio H; Vicente J
Eur Urol; 1992; 21(2):110-4. PubMed ID: 1499609
[TBL] [Abstract][Full Text] [Related]
10. Guidelines on diagnosis and treatment of superficial bladder cancer.
Oosterlinck W
Minerva Urol Nefrol; 2004 Mar; 56(1):65-72. PubMed ID: 15195031
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
Brake M; Loertzer H; Horsch R; Keller H
Urology; 2000 May; 55(5):673-8. PubMed ID: 10792077
[TBL] [Abstract][Full Text] [Related]
12. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
Schulze M; Stotz N; Rassweiler J
J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of high grade superficial bladder tumours.
Trinchieri A; Bonacina P; Butti A; Cappoli S; Esposito N; Invernizzi S; Librizzi A; Locatelli G
Arch Ital Urol Androl; 2005 Dec; 77(4):215-8. PubMed ID: 16444936
[TBL] [Abstract][Full Text] [Related]
15. Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
Herr HW; Schwalb DM; Zhang ZF; Sogani PC; Fair WR; Whitmore WF; Oettgen HF
J Clin Oncol; 1995 Jun; 13(6):1404-8. PubMed ID: 7751885
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
[TBL] [Abstract][Full Text] [Related]
17. Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.
Hurle R; Losa A; Manzetti A; Lembo A
Urology; 1999 Aug; 54(2):258-63. PubMed ID: 10443721
[TBL] [Abstract][Full Text] [Related]
18. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
19. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
Herr HW
J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
[TBL] [Abstract][Full Text] [Related]
20. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
